| Indolent B-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived109 of 109show fewer |
|---|
| → investigated in trials for | Rituximabmonoclonal antibody 124 trials (42 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 124 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 62 trials (12 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 56 trials (16 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 36 trials (15 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 28 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 27 trials (17 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall_molecule 24 trials (9 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 19 trials (11 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibritumomab Tiuxetanmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |